VIDEO: BCT makes history with HK’s first fully approved cancer drug

Cancer continues to afflict millions of people every year. Paul Cheng, Co-founder and CEO, BCT International, reveals how his team created Hong Kong’s first cancer drugs to treat malignancies and auto-immune disorders which could save countless lives facing the pain of prostate, skin and liver cancers.